South Korea Apheresis Market Insight
Published: 01 June 2026 | Report Format: Electronic (PDF)
The market for apheresis in South Korea is expected to grow with a CAGR of 7.4% due to growing incidences of blood disorders, increasing need for plasma-based products, blood donation drives.
South Korea Apheresis Market Insights Forecasts to 2035
- The South Korea Apheresis Market Size Was Estimated USD 214.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.4% from 2025 to 2035
- The South Korea Apheresis Market Size is Expected to rise to around USD 438.6 Million by 2035
Notable Insights for the South Korea Apheresis Market
- The Therapeutic Apheresis segment held about 54% of the South Korea Apheresis Market share in 2025, driven by the rising need for treatments of autoimmune disorders, hematological disorders, and neurological disorders.
- The Hospitals & Blood Centers segment held around 59% market share in 2025, driven by an increase in the number of procedures for blood component collection, plasma donations, and increased transfusion medicine usage in South Korea.
- The expected global revenue generated from Terumo Blood and Cell Technologies was above USD 1.2 billion in 2025, fueled by the rising demand for blood component separators and cell therapy automation solutions.
- Increased focus on the development of AI-powered blood management systems, plasma collection automation, and donor monitoring systems is driving market growth, wherein the adoption of advanced apheresis technologies increases the efficacy of blood component collection by 42% and the efficacy of therapeutic treatment by nearly 33%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea Apheresis Market
The South Korea apheresis market is analyzed using primary and secondary research methodologies to provide accurate market insights and forecasts. Primary research includes interviews with healthcare providers, blood banks, medical device manufacturers, hospitals, and industry experts to assess treatment demand and technology adoption. Secondary research involves reviewing company reports, government healthcare policies, medical journals, and import-export statistics related to blood component separation technologies. Quantitative and qualitative analytical models are used to estimate market revenue, pricing trends, and competitive positioning. The study indicates therapeutic apheresis procedures account for over 54% of market demand across South Korea.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Apheresis Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Apheresis Market
- Terumo Blood and Cell Technologies
- Fresenius Kabi AG
- Haemonetics Corporation
- Asahi Kasei Medical Co., Ltd.
- Baxter International Inc.
- Nikkiso Co., Ltd.
- B. Braun Melsungen AG
- Kawasumi Laboratories Inc.
- Cerus Corporation
- Macopharma SA
Recent Developments:
- In February 2026, South Korea expanded investments in blood donation infrastructure, plasma-derived therapeutics manufacturing, and smart transfusion medicine systems supporting long-term demand for advanced apheresis technologies.
- In November 2025, Asahi Kasei Medical accelerated investments in therapeutic plasma exchange technologies and advanced membrane-based blood purification systems supporting hematology and critical care treatment applications.
Market Segmentation:
South Korea Apheresis Market, By Procedure Type
- Therapeutic Apheresis
- Donor Apheresis
South Korea Apheresis Market, By Technology
- Automated Cell Separation Systems
- AI-Based Blood Management Platforms
- Smart Donor Monitoring Systems
- Therapeutic Plasma Exchange Technologies
South Korea Apheresis Market, By End User
- Hospitals & Blood Centers
- Specialty Clinics
- Research Institutes
- Ambulatory Care Centers
Expert Views:
The market for apheresis in South Korea is projected to grow sustainably over the long term, owing to growing cases of hematological diseases, rising need for plasma collection, and increased use of automated blood processing techniques. The application of AI-based donor management solutions, automated therapeutic plasma exchange systems, intelligent blood tracking infrastructure, and efficient cell separation solutions is expected to enhance treatment effectiveness and drive long-term demand in transfusion medicine systems, plasma-based therapeutic product manufacturing, hematology therapy systems, and healthcare facilities in South Korea.
Author: Govind and Krishna By Spherical Insights and Consulting